An observational multi-centre retrospective research study to describe the real world use of adalimumab in UK patients with ulcerative colitis
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Adalimumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 30 Mar 2016 Status changed from active, no longer recruiting to completed.
- 26 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
- 30 Apr 2015 New trial record